Clincosm LogoSign in Get a demo

hodgkin lymphoma

Showing 51 - 75 of 232
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

Not yet recruiting
  • Acute Leukemia in Remission
  • +6 more
  • Fecal Microbiota Transplantation
  • Amiens, France
  • +19 more
Oct 18, 2022

Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

Completed
Has Results
  • Hodgkin Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Campath
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Valhalla, New York
    New York Medical College
Sep 27, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Hodgkin Lymphoma, Coexisting Medical Conditions Trial in Belgium, France (Nivolumab, Vinblastin)

Completed
  • Hodgkin Lymphoma
  • Coexisting Medical Conditions
  • Antwerpen, Belgium
  • +50 more
Aug 18, 2022

Hodgkin Lymphoma Trial in Worldwide (Doxorubicin, Bleomycin, Vinblastine)

Completed
  • Hodgkin Lymphoma
  • Antwerpen, Belgium
  • +64 more
Aug 18, 2022

Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • brentuximab vedotin
  • (no location specified)
Aug 18, 2022

Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

Not yet recruiting
  • Hodgkin Lymphoma
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Aug 18, 2022

Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • gemcitabine, cisplatin and tislelizumab
  • Brussels, Belgium
  • +14 more
Aug 12, 2022

Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

Recruiting
  • Lung Cancer
  • +8 more
  • Home-based cardiac rehabilitation
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 9, 2022

Hodgkin Lymphoma Trial in Cologne (B-CAP, Brentuximab Vedotin)

Active, not recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Dept. of Medicine, Cologne University Hospital
Aug 5, 2022

Hodgkin Lymphoma Trial in Guadalajara (Pentoxifylline, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Aug 4, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • (no location specified)
Jul 28, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Frailty in Young Adult Survivors of Childhood Cancer

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 8, 2022

    Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))

    Recruiting
    • Multiple Myeloma
    • +13 more
    • RITA (App)
    • Milano, Italy
      ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
    Jul 6, 2022

    A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

    Recruiting
    • Hodgkin Lymphoma
    • No Intervention
    • Wroclaw, Dolnoslskie, Poland
    • +14 more
    Jun 23, 2022

    Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

    Recruiting
    • Hodgkin Lymphoma
    • +3 more
    • Stanford, California
      Stanford University
    Jun 21, 2022

    Blood Clots and Bleeding in Hematological Malignancies, HAT

    Recruiting
    • Acute Leukemia
    • +7 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jun 17, 2022

    Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

    Recruiting
    • Non-hodgkin Lymphoma
    • Hodgkin Lymphoma
    • DOC Group B
    • +16 more
    • Valhalla, New York
      New York Medical College
    Jun 9, 2022

    Hodgkin Lymphoma Trial (pembrolizumab)

    Active, not recruiting
    • Hodgkin Lymphoma
    • pembrolizumab
    • (no location specified)
    May 30, 2022

    Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

    Recruiting
    • Hodgkin Lymphoma
    • Involved site radiotherapy
    • +6 more
    • Aberdeen, United Kingdom
    • +6 more
    May 24, 2022

    Early Ageing During Therapy in AYA Cancer Patients

    Recruiting
    • Cancer
    • +7 more
    • Blood sampling
    • Groningen, Netherlands
      University Medical Center Groningen
    May 17, 2022

    Hodgkin Lymphoma Trial in Philadelphia (Nivolumab)

    Terminated
    • Hodgkin Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    May 20, 2022